The global negative pressure wound therapy (NPWT) market size is projected to reach USD 2.74 billion by 2026, exhibiting a CAGR of 5.1% during the forecast period. However, it stood at USD 1.85 billion in 2018.Fortune Business Insights™ published this information in a recent study, titled, “Negative Pressure Wound Therapy (NPWT) Market Size, Share & Industry Analysis, By Device Type (Conventional NPWT, and Single-use NPWT), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Burns & Trauma, and Others), By End User (Hospitals, Clinics, Homecare Settings, and Others) and Regional Forecast, 2019-2026.” As per the study, there is an increasing incidence of surgical site infections and chronic wounds amongst the masses worldwide. Thus, such factors would affect the market positively in the coming years.

Increasing Cases of Diabetic Foot Ulcer to Drive Growth
Nowadays, there exists a large patient pool across the world that are affected by chronic diseases, such as diabetes. Such conditions are further giving rise to diabetic foot ulcers. As per a published report byNHS, for instance, approximately 4.5 million people were affected by diabetes in the U.K. in 2017. Also, around 10.0% of that diabetic population developed foot ulcer at some point in their lives. Additionally, as the geriatric population is rising, the cases of various conditions and diseases is also upsurging. It is, in turn, causing reduced mobility amongst the affected populaces. These would contribute to the vacuum assisted closure devices market growth during the forecast period.

For More Information : https://www.fortunebusinessinsights.com/industry-reports/negative-pressure-wound-therapy-npwt-devices-market-101243

North America to Grow Significantly Stoked by High Treatment Cost
In terms of region, the market is grouped into the Middle East and Africa, North America, Asia Pacific, Europe, and Latin America. Out of these, North America had acquired USD 738.1 millionNPWT market revenue in 2018 and is expected to expand steadily in the forthcoming years. This growth is attributable to the high treatment cost and rising incidence of chronic wounds in the U.S. Europe would showcase a slow growth owing to the inadequate reimbursement policies in countries, namely, Italy, Spain, and France.

Asia Pacific, on the other hand, is anticipated to grow significantly by exhibiting a high CAGR. It is likely to occur because of the rising patient pool affected by chronic wounds, as well as an increasing prevalence of chronic diseases. The Middle East & Africa and Latin America would show a moderate CAGR on account of the unavailability of favorable reimbursement policies and expensive nature of treatments.
More Trending Topics from Fortune Business Insights :
Human Insulin Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
Human Insulin Market to Reach USD 27.71 Billion by 2026, Technological Advancements in Insulin Pens to Spur Growth: Fortune Business Insights